(Q44590151)

4 December 2017

title

Captopril and enalaprilat decrease antioxidant defences in human endothelial cells and are unable to protect against apoptosis (English)

1 reference

4 December 2017

0 references

1 reference

https://api.crossref.org/works/10.1016/S1065-6995(03)00162-8

11 March 2024

author name string

Agnès Mailloux

1

1 reference

4 December 2017

Benjamin Deslandes

2

1 reference

4 December 2017

Michel Vaubourdolle

3

1 reference

4 December 2017

Bruno Baudin

4

1 reference

4 December 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14499662

11 March 2024

publication date

1 January 2003

1 reference

full work available at URL

4 December 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1016%2FS1065-6995(03)00162-8

1 reference

https://api.crossref.org/works/10.1016/S1065-6995(03)00162-8

https://onlinelibrary.wiley.com/doi/pdf/10.1016/S1065-6995%2803%2900162-8

11 March 2024

1 reference

https://api.crossref.org/works/10.1016/S1065-6995(03)00162-8

Cell Biology International

11 March 2024

published in

1 reference

4 December 2017

volume

27

1 reference

4 December 2017

issue

10

1 reference

4 December 2017

page(s)

825-830

1 reference

ACE-inhibitors and atherosclerosis

4 December 2017

cites work

3

1 reference

https://api.crossref.org/works/10.1016/S1065-6995(03)00162-8

Evaluation of the ability of the angiotensin-converting enzyme inhibitor captopril to scavenge reactive oxygen species

11 March 2024

4

1 reference

https://api.crossref.org/works/10.1016/S1065-6995(03)00162-8

Antioxidant and prooxidant properties of captopril and enalapril

11 March 2024

5

1 reference

https://api.crossref.org/works/10.1016/S1065-6995(03)00162-8

Cytotoxicity of amiodarone in cultured human endothelial cells

11 March 2024

8

1 reference

https://api.crossref.org/works/10.1016/S1065-6995(03)00162-8

Vascular origin determines angiotensin I-converting enzyme expression in endothelial cells

11 March 2024

9

1 reference

https://api.crossref.org/works/10.1016/S1065-6995(03)00162-8

New aspects on angiotensin-converting enzyme: from gene to disease

11 March 2024

10

1 reference

https://api.crossref.org/works/10.1016/S1065-6995(03)00162-8

Antioxidant power of angiotensin-converting enzyme inhibitors in vitro.

11 March 2024

11

1 reference

https://api.crossref.org/works/10.1016/S1065-6995(03)00162-8

Angiotensin-Converting Enzyme Inhibitors

11 March 2024

12

1 reference

https://api.crossref.org/works/10.1016/S1065-6995(03)00162-8

Potential mechanisms for the effect of angiotensin-converting enzyme inhibitors on endothelial dysfunction: the role of nitric oxide

11 March 2024

13

1 reference

https://api.crossref.org/works/10.1016/S1065-6995(03)00162-8

Endothelial dysfunctions: common denominators in vascular disease

11 March 2024

14

1 reference

https://api.crossref.org/works/10.1016/S1065-6995(03)00162-8

Superoxide dismutase and glutathione peroxidase activities are increased by enalapril and captopril in mouse liver

11 March 2024

15

1 reference

https://api.crossref.org/works/10.1016/S1065-6995(03)00162-8

Enalapril attenuates oxidative stress in diabetic rats

11 March 2024

17

1 reference

https://api.crossref.org/works/10.1016/S1065-6995(03)00162-8

Prevention of doxorubicin cardiac toxicity in the mouse by N-acetylcysteine

11 March 2024

18

1 reference

https://api.crossref.org/works/10.1016/S1065-6995(03)00162-8

Endothelial dysfunction in heart failure and potential for reversal by ACE inhibition

11 March 2024

19

1 reference

https://api.crossref.org/works/10.1016/S1065-6995(03)00162-8

Endothelial dysfunction: clinical implications

11 March 2024

20

1 reference

https://api.crossref.org/works/10.1016/S1065-6995(03)00162-8

Blockade of apoptosis by ACE inhibitors and angiotensin receptor antagonists

11 March 2024

21

1 reference

https://api.crossref.org/works/10.1016/S1065-6995(03)00162-8

Inhibition of angiotensin-converting enzyme by captopril: a novel approach to reduce ischemia-reperfusion injury after lung transplantation

11 March 2024

22

1 reference

https://api.crossref.org/works/10.1016/S1065-6995(03)00162-8

Delapril slows the progression of atherosclerosis and maintains endothelial function in cholesterol-fed rabbits

11 March 2024

23

1 reference

https://api.crossref.org/works/10.1016/S1065-6995(03)00162-8

Antiatherosclerotic effects of the angiotensin-converting enzyme inhibitors captopril and fosinopril in hypercholesterolemic minipigs

11 March 2024

24

1 reference

https://api.crossref.org/works/10.1016/S1065-6995(03)00162-8

Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria

11 March 2024

25

1 reference

https://api.crossref.org/works/10.1016/S1065-6995(03)00162-8

Suppression by metallothionein of doxorubicin-induced cardiomyocyte apoptosis through inhibition of p38 mitogen-activated protein kinases

11 March 2024

26

1 reference

https://api.crossref.org/works/10.1016/S1065-6995(03)00162-8

Doxorubicin (adriamycin): a critical review of free radical-dependent mechanisms of cytotoxicity

11 March 2024

27

1 reference

https://api.crossref.org/works/10.1016/S1065-6995(03)00162-8

Enhanced reduction of atherosclerosis in hamsters treated with pravastatin and captopril: ACE in atheromas provides cellular targets for captopril

11 March 2024

28

1 reference

https://api.crossref.org/works/10.1016/S1065-6995(03)00162-8

Interleukin-1-induced nitric oxide production modulates glutathione synthesis in cultured rat hepatocytes

11 March 2024

29

1 reference

https://api.crossref.org/works/10.1016/S1065-6995(03)00162-8

Endothelial injury caused by antineoplastic agents

11 March 2024

30

1 reference

https://api.crossref.org/works/10.1016/S1065-6995(03)00162-8

A clinicopathologic analysis of adriamycin cardiotoxicity

11 March 2024

31

1 reference

https://api.crossref.org/works/10.1016/S1065-6995(03)00162-8

An angiotensin-converting enzyme inhibitor protects against doxorubicin-induced impairment of calcium handling in neonatal rat cardiac myocytes

11 March 2024

33

1 reference

https://api.crossref.org/works/10.1016/S1065-6995(03)00162-8

Anticancer drugs induce necrosis of human endothelial cells involving both oncosis and apoptosis

11 March 2024

34

1 reference

https://api.crossref.org/works/10.1016/S1065-6995(03)00162-8

Enhanced NO production during Mg deficiency and its role in mediating red blood cell glutathione loss.

11 March 2024

35

1 reference

https://api.crossref.org/works/10.1016/S1065-6995(03)00162-8

The induction of GSH synthesis by nanomolar concentrations of NO in endothelial cells: a role for γ-glutamylcysteine synthetase and γ-glutamyl transpeptidase

11 March 2024

37

1 reference

https://api.crossref.org/works/10.1016/S1065-6995(03)00162-8

Angiotensin-converting enzyme inhibitor captopril prevents activation-induced apoptosis by interfering with T cell activation signals

11 March 2024

38

1 reference

https://api.crossref.org/works/10.1016/S1065-6995(03)00162-8

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

11 March 2024

40

1 reference

https://api.crossref.org/works/10.1016/S1065-6995(03)00162-8

Temocapril, an angiotensin converting enzyme inhibitor, protects against diabetes-induced endothelial dysfunction.

11 March 2024

41

1 reference

https://api.crossref.org/works/10.1016/S1065-6995(03)00162-8

Captopril: pharmacokinetics, antihypertensive and biological effects in hypertensive patients

11 March 2024

42

1 reference

https://api.crossref.org/works/10.1016/S1065-6995(03)00162-8

Cardioprotective effects of zofenopril, a new angiotensin-converting enzyme inhibitor, on doxorubicin-induced cardiotoxicity in the rat.

11 March 2024

43

1 reference

https://api.crossref.org/works/10.1016/S1065-6995(03)00162-8

Liver veno-occlusive disease after bone marrow transplantation changes in coagulation parameters and endothelial markers

11 March 2024

44

1 reference

https://api.crossref.org/works/10.1016/S1065-6995(03)00162-8

Adriamycin-stimulated hydroxyl radical formation in human breast tumor cells

11 March 2024

45

1 reference

https://api.crossref.org/works/10.1016/S1065-6995(03)00162-8

Endothelial dysfunction and pathogenesis of diabetic angiopathy

11 March 2024

46

1 reference

https://api.crossref.org/works/10.1016/S1065-6995(03)00162-8

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

11 March 2024

47

1 reference

https://api.crossref.org/works/10.1016/S1065-6995(03)00162-8

Prevention of doxorubicin (adriamycin)-induced cardiomyopathy by simultaneous administration of angiotensin-converting enzyme inhibitor assessed by acoustic densitometry

11 March 2024

48

1 reference

https://api.crossref.org/works/10.1016/S1065-6995(03)00162-8

Usefulness of a free radical scavenger in preventing doxorubicin-induced heart failure in dogs

11 March 2024

50

1 reference

https://api.crossref.org/works/10.1016/S1065-6995(03)00162-8

Induction of antioxidants by adriamycin in mouse heart

11 March 2024

52

1 reference

https://api.crossref.org/works/10.1016/S1065-6995(03)00162-8

11 March 2024

Identifiers

1 reference

4 December 2017

1 reference